Literature DB >> 8033308

In vivo metabolism of butadiene by mice and rats: a comparison of physiological model predictions and experimental data.

M A Medinsky1, T L Leavens, G A Csanády, M L Gargas, J A Bond.   

Abstract

1,3-Butadiene (BD), a rodent carcinogen, is metabolized to mutagenic and potentially DNA-reactive epoxides, including butadiene monoepoxide (BMO) and butadiene diepoxide. A physiological model containing five tissue groups (liver, lung, fat, slowly perfused tissues and rapidly perfused tissues) and blood was developed to describe uptake and metabolism of inhaled BD and BMO. Maximal rates for hepatic and pulmonary metabolism of BD and hepatic metabolism of BMO incorporated into the model were extrapolated from in vitro data (Csanády et al., Carcinogenesis, 13, 1143-1153, 1992). Apparent enzyme affinities used in the model were identified to the values measured in vitro. Model stimulations for BD and BMO uptake were compared to results from experiments in which groups of male Sprague-Dawley rats and B6C3F1 mice were exposed to initial concentrations of 50-5000 p.p.m. BD in closed chamber experiments and published data on BMO uptake by rats and mice. Metabolic rate constants extrapolated from in vitro data stimulated both BMO and BD uptake from closed chambers. The Vmax for hepatic metabolism of BD extrapolated from in vitro studies was 62 mumol/kg/h for rats and 340 mumol/kg/h for mice, while the Vmax for pulmonary metabolism of BD was 1.0 and 22 for rats and mice, respectively. These results demonstrate the usefulness of data derived in vitro for predicting in vivo behavior. Model simulations were also conducted in which only hepatic metabolism of BD was incorporated. These simulations underestimated BD uptake for mice, but not rats. Inclusion of in vitro-derived rates of pulmonary metabolism of BD into the model improved the fit to the data for mice. Since mice, but not rats, develop lung tumors after exposure to BD, these results point to the need for further characterize the metabolic capacity and target cells in the lung for BD and its metabolites. Once characterized, these models can be extended to predict in vivo behavior of BD in humans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033308     DOI: 10.1093/carcin/15.7.1329

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

Review 1.  The use of toxicologic data in mechanistic risk assessment: 1,3-butadiene as a case study.

Authors:  J A Bond; M W Himmelstein; M A Medinsky
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

2.  A preliminary physiologically based pharmacokinetic model for naphthalene and naphthalene oxide in mice and rats.

Authors:  L M Sweeney; M L Shuler; D J Quick; J G Babish
Journal:  Ann Biomed Eng       Date:  1996 Mar-Apr       Impact factor: 3.934

3.  Physiologically based kinetic modelling based prediction of in vivo rat and human acetylcholinesterase (AChE) inhibition upon exposure to diazinon.

Authors:  Shensheng Zhao; Sebastiaan Wesseling; Bert Spenkelink; Ivonne M C M Rietjens
Journal:  Arch Toxicol       Date:  2021-03-14       Impact factor: 5.153

4.  Use of Physiologically Based Kinetic Modeling to Predict Rat Gut Microbial Metabolism of the Isoflavone Daidzein to S-Equol and Its Consequences for ERα Activation.

Authors:  Qianrui Wang; Bert Spenkelink; Rungnapa Boonpawa; Ivonne M C M Rietjens; Karsten Beekmann
Journal:  Mol Nutr Food Res       Date:  2020-02-25       Impact factor: 5.914

5.  Prediction of dose-dependent in vivo acetylcholinesterase inhibition by profenofos in rats and humans using physiologically based kinetic (PBK) modeling-facilitated reverse dosimetry.

Authors:  Isaac Omwenga; Shensheng Zhao; Laetitia Kanja; Hans Mol; Ivonne M C M Rietjens; Jochem Louisse
Journal:  Arch Toxicol       Date:  2021-03-02       Impact factor: 5.153

6.  Physiologically based kinetic modelling predicts the in vivo relative potency of riddelliine N-oxide compared to riddelliine in rat to be dose dependent.

Authors:  Frances Widjaja; Sebastiaan Wesseling; Ivonne M C M Rietjens
Journal:  Arch Toxicol       Date:  2021-10-20       Impact factor: 5.153

7.  Use of physiologically based biokinetic (PBBK) modeling to study estragole bioactivation and detoxification in humans as compared with male rats.

Authors:  Ans Punt; Alicia Paini; Marelle G Boersma; Andreas P Freidig; Thierry Delatour; Gabriele Scholz; Benoît Schilter; Peter J van Bladeren; Ivonne M C M Rietjens
Journal:  Toxicol Sci       Date:  2009-05-15       Impact factor: 4.849

8.  Physiologically based kinetic modeling of the bioactivation of myristicin.

Authors:  Amer J Al-Malahmeh; Abdelmajeed Al-Ajlouni; Sebastiaan Wesseling; Ans E M F Soffers; Ala' Al-Subeihi; Reiko Kiwamoto; Jacques Vervoort; Ivonne M C M Rietjens
Journal:  Arch Toxicol       Date:  2016-06-22       Impact factor: 5.153

9.  Monocrotaline-induced liver toxicity in rat predicted by a combined in vitro physiologically based kinetic modeling approach.

Authors:  Suparmi Suparmi; Sebastiaan Wesseling; Ivonne M C M Rietjens
Journal:  Arch Toxicol       Date:  2020-06-09       Impact factor: 5.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.